Establishing protocol for detecting methylation of Ubiquitin carboxyl terminal hydrolase 1 gene’s promoter in nasopharyngeal carcinoma
Authors
-
Thieu Hong Hue
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Huynh Thi Ngoc Tuyen
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Nguyen Van Truong
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Dao Duy Tin
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Tran Minh Dang Khoa
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Le Huyen Ai Thuy
Ho Chi Minh City Open University, Ho Chi Minh City, VN
-
Lao Duc Thuan
thuan.ld@ou.edu.vn
Ho Chi Minh City Open University, Ho Chi Minh City, VNhttps://orcid.org/0000-0002-6459-3058
DOI:
10.46223/HCMCOUJS.tech.en.12.2.2542.2022Keywords:
epigenetics; methylation; Nested-MSP; Ubiquitin carboxyl terminal hydrolase 1; unmethylationAbstract
Background: The methylation of Ubiquitin Carboxyl Terminal Hydrolase 1 (UCHL1) gene’s promoter has been reported as the etiological factor of nasopharyngeal tumorigenesis. Purpose: This study is designed to establish a protocol for detecting methylation of UCHL1 gene’s promoter in nasopharyngeal carcinoma (NPC) in a Vietnamese population. Materials and methods: 10 samples of NPC biopsy tissues and 10 samples of non-cancerous swabs were collected from the local hospital. Chloroform/Phenol method and Nested-MSP assays were established to detect methylation of a target gene. Results: The isolated DNA reached purity and high concentration which were confirmed by the method of absorbance measurement at 260nm and 280nm. Additionally, the Nested-MSP products of methylation or unmethylation were analyzed and visualized in the agarose gel with the band of 169bps and 210bps, respectively. By sequencing, it was confirmed that the two sets of primer could distinguish the status of methylation and unmethylation of UCHL1 gene’s promoter. Conclusion: Our data suggested that the current protocol could successfully identify the status of methylation and/or unmethylation of UCHL1 gene’s promoter.Downloads
Download data is not yet available.References
Dai, W., Zheng, H., Cheung, A. K., & Lung, M. L. (2016). Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chinese Clinical Oncology, 5(2), Article 16. doi:10.21037/cco.2016.03.06
Divine, K. K., Liechty, K. C., Crume, K. C., & Belinsky, S. A. (2006). Nested multigene MSP/DHPLC method for analyzing promoter hypermethylation status in clinical samples. BioTechniques, 40(1), 40-48. doi:10.2144/000112095
Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A., … Arancio, O. (2006). Ubiquitin hydrolase Uch-L1 rescues beta-amyloid-induced decreases in synaptic function and contextual memory. Cell, 126(4), 775-788. doi:10.1016/j.cell.2006.06.046
Goto, Y., Zeng, L., Yeom, C. J., Zhu, Y., Morinibu, A., Shinomiya, K., … Harada, H. (2015). UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α. Nature Communications, 6(1), 1-13. doi:10.1038/ncomms7153
Han, B., Yang, X., Zhang, P., Zhang, Y., Tu, Y., He, Z., … Sun, H. (2020). DNA methylation biomarkers for nasopharyngeal carcinoma. PloS One, 15(4), Article e0230524. doi:10.1371/journal.pone.0230524
Herceg, Z., & Hainaut, P. (2007). Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Molecular Oncology, 1(1), 26-41. doi:10.1016/j.molonc.2007.01.004
Hussain, S., Bedekovics, T., Liu, Q., Hu, W., Jeon, H., Johnson, S. H., … Galardy, P. J. (2018). UCH-L1 bypasses mTOR to promote protein biosynthesis and is required for MYC-driven lymphomagenesis in mice. Blood, The Journal of the American Society of Hematology, 132(24), 2564-2574. doi:10.1182/blood-2018-05-848515
Lao, T. D., Nguyen, T. N., & Le, T. (2021). Promoter hypermethylation of tumor suppressor genes located on short arm of the chromosome 3 as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Diagnostics, 11(8), Article 1404. doi:10.3390/diagnostics11081404
Lao, T. D., Truong, P. K., Thieu, H. H., Nguyen, D. H., Nguyen, M. T., & Le, T. (2021). Simultaneously both expression of LMP-1 and methylation of e-cadherin: Molecular biomarker in stage IV of nasopharyngeal carcinoma patients. Balkan Journal of Medical Genetics: BJMG, 24(1), 57-66. doi:10.2478/bjmg-2021-0005
Li, L., Tao, Q., Jin, H., van Hasselt, A., Poon, F. F., Wang, X., … Cao, Y. (2010). The tumor suppressor UCHL1 forms a complex with p53/MDM2/ARF to promote p53 signaling and is frequently silenced in nasopharyngeal carcinoma. Clinical Cancer Research, 16(11), 2949-2958. doi:10.1158/1078-0432.CCR-09-3178
Licchesi, J. D., & Herman, J. G. (2009). Methylation-specific PCR. In DNA methylation (pp. 305-323). New York, NY: Humana Press.
Loyo, M., Brait, M., Kim, M. S., Ostrow, K. L., Jie, C. C., Chuang, A. Y., … Sidransky, D. (2011). A survey of methylated candidate tumor suppressor genes in nasopharyngeal carcinoma. International Journal of Cancer, 128(6), 1393-1403. doi:10.1002/ijc.25443
Moore, L. D., Le, T., & Fan, G. (2013). DNA methylation and its basic function. Neuropsychopharmacology, 38(1), 23-38. doi:10.1038/npp.2012.112
Nijman, S. M., Luna-Vargas, M. P., Velds, A., Brummelkamp, T. R., Dirac, A. M., Sixma, T. K., & Bernards, R. (2005). A genomic and functional inventory of deubiquitinating enzymes. Cell, 123(5), 773-786. doi:10.1016/j.cell.2005.11.007
Olson, N. D., & Morrow, J. B. (2012). DNA extract characterization process for microbial detection methods development and validation. BMC Research Notes, 5(1), 1-14. doi:10.1186/1756-0500-5-668
Sharma, S., Kelly, T. K., & Jones, P. A. (2010). Epigenetics in cancer. Carcinogenesis, 31(1), 27-36. doi:10.1093/carcin/bgp220
Tian, F., Yip, S. P., Kwong, D. L., Lin, Z., Yang, Z., & Wu, V. W. (2013). Promoter hypermethylation of tumor suppressor genes in serum as potential biomarker for the diagnosis of nasopharyngeal carcinoma. Cancer Epidemiology, 37(5), 708-713. doi:10.1016/j.canep.2013.05.012
Tsao, S. W., Yip, Y. L., Tsang, C. M., Pang, P. S., Lau, V. M., Zhang, G., & Lo, K. W. (2014). Etiological factors of nasopharyngeal carcinoma. Oral Oncology, 50(5), 330-338. doi:10.1016/j.oraloncology.2014.02.006
Wilfinger, W. W., Mackey, K., & Chomczynski, P. (2006). Assessing the quantity, purity and integrity of RNA and DNA following nucleic acid purification. In DNA sequencing II optimizing preparation and cleanup (vol. 291, p. 312). Burlington, MA: Jones and Bartlett Publishers.
Yu, J., Tao, Q., Cheung, K. F., Jin, H., Poon, F. F., Wang, X., … Sung, J. J. (2008). Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors. Hepatology, 48(2), 508-518. doi:10.1002/hep.22343
Zhao, Y., Lei, Y., He, S. W., Li, Y. Q., Wang, Y. Q., Hong, X. H., … Tang, L. L. (2020). Hypermethylation of UCHL1 Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing Degradation of Cortactin (CTTN). Cells, 9(3), Article 559. doi:10.3390/cells9030559
Downloads
Received: 03-10-2022Accepted: 24-10-2022Published: 04-11-2022Statistics Views
Abstract: 324 PDF: 269How to Cite
Hue, T. H., Tuyen, H. T. N., Truong, N. V., Tin, D. D., Khoa, T. M. D., Thuy, L. H. A., & Thuan, L. D. (2022). Establishing protocol for detecting methylation of Ubiquitin carboxyl terminal hydrolase 1 gene’s promoter in nasopharyngeal carcinoma. HO CHI MINH CITY OPEN UNIVERSITY JOURNAL OF SCIENCE - ENGINEERING AND TECHNOLOGY, 12(2), 34–41. https://doi.org/10.46223/HCMCOUJS.tech.en.12.2.2542.2022License
Copyright (c) 2022 Thieu Hong Hue; Huynh Thi Ngoc Tuyen; Nguyen Van Truong; Dao Duy Tin; Tran Minh Dang Khoa; Le Huyen Ai Thuy; Lao Duc Thuan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
